📰 John Simard News
Page 3 - John Simard News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from John Simard. Real-time updates on events, politics, business and more.
October 6, 2022
Wokeness killed another holiday celebration where kids could have fun. This move should be condemned, not celebrated as inclusive.
March 5, 2022
TheStreet downgraded shares of XBiotech (NASDAQ:XBIT – Get Rating) from a c- rating to a d+ rating in a report issued on Tuesday, TheStreetRatingsTable reports. NASDAQ:XBIT opened at $9.41 on Tuesday. The stock’s 50-day simple moving average is $10.50 and its 200 day simple moving average is $12.75. The company has a market cap of […]
February 2, 2022
XBiotech Manufacturing Antibody Drug for Janssen Research & Development, LLC (Janssen), One of the Janssen Pharmaceutical Companies of Johnson & JohnsonAUSTIN, Texas, Feb. 02, 2022 (GLOBE NEWSWIRE) --
October 28, 2021
Company Commencing Phase I/II Study to Test Safety and Efficacy of its New Drug Candidate to Reduce Brain Injury After StrokeAUSTIN, Texas, Oct. 28, 2021 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced
June 24, 2021
Beurteilung von XB2001 zur Behandlung von Bauchspeicheldrüsenkrebs bekannt XB2001 ist eine neuartige Therapie zur Entzündungsunterbrechung, die möglicherweise Wachstum und Ausbreitung von Tumoren blockiert und die Toxizität von Chemotherapien reduziert AUSTIN, Texas, June 23, 2021 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) hat den ersten Patienten in seine Studie 1-BETTER aufgenommen. Dabei handelt es sich um eine randomisierte, doppelblinde, placebokontrollierte klinische Studie zur ...
April 19, 2021
(1) XBiotechs New Drug to Enter Clinical Studies in Combination Therapy for Pancreatic Cancer AUSTIN, Texas, April 19, 2021 (GLOBE NEWSWIRE) -- XBiotech (NASDAQ: XBIT) announced today that the FDA has granted permission to commence clinical trials with its novel drug candidate for treating patients with pancreatic cancer. From 1992 to 2018 the death rate from pancreatic cancer steadily increased in the USA. It is now predicted that pancreatic cancer will claim 48,220 lives and be the 3 rd leadi...
January 19, 2021
XBiotech Announces Cerebrovascular Medical Advisory Board & Development of New Stroke Therapy Appointments Include: Chair, Clay Johnston, M.D., Ph.D. as well as Members Greg Albers, M.D. and Brett Cucchiara, M.D. AUSTIN, Texas, Jan. 19, 2021 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) announced today the first meeting of its Cerebrovascular Medical Advisory Board (CMAB). The CMAB is comprised of key opinion leaders who specialize in cerebrovascular diseases including ischemic stroke, whi...
January 19, 2021
XBiotech Announces Cerebrovascular Medical Advisory Board & Development of New Stroke Therapy XBiotech Announces Cerebrovascular Medical Advisory Board & Development of New Stroke Therapy AUSTIN, Texas, Jan. 19, 2021 — XBiotech Inc. (NASDAQ: XBIT) announced today the first meeting of its Cerebrovascular Medical Advisory Board (CMAB). The CMAB is comprised of key opinion leaders who specialize in cerebrovascular diseases including ischemic stroke, which is the third leading cause of death and ...